GlassScriptPhysician profile
Nelson R Ploch
NPI 1205824489
$9,793.81
in general payments reported to CMS, 2019-2025
65 companies · $1,602 in 2025
The $1,602 reported for 2025 was more than what 75% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,390 · 2020: $984 · 2021: $1,087 · 2022: $1,383 · 2023: $1,607 · 2024: $1,740 · 2025: $1,602.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,944 · Education: $4.85.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,944.42 |
| Education | $4.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $1,360.29 | 2019-2025 | Xtandi, Myrbetriq, Veozah |
| Pfizer INC. | $1,086.08 | 2019-2025 | |
| Sumitomo Pharma America, INC. | $861.30 | 2023-2025 | Gemtesa, Orgovyx |
| Endo Pharmaceuticals INC. | $608.35 | 2019-2024 | Xiaflex |
| Coloplast Corp | $400.95 | 2019-2024 | Speedicath |
| Abbvie INC. | $364.88 | 2020-2025 | |
| Antares Pharma, INC. | $313.45 | 2019-2024 | Xyosted |
| Janssen Biotech, INC. | $257.90 | 2019-2025 | Erleada |
| Axonics, INC. | $252.05 | 2021-2024 | Axonics |
| Teleflex LLC | $240.25 | 2021-2025 | Urolift, Barrigel |
| Blue Earth Diagnostics | $238.50 | 2019-2024 | |
| Boston Scientific Corporation | $227.17 | 2019-2025 | Rezum Generator, Axonics |
| Urovant Sciences INC | $221.48 | 2021-2022 | |
| Rochester Medical Corporation | $210.38 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $197.76 | 2020-2025 | Keytruda, Lynparza, Welireg |
Show all 65 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nelson Ploch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.